Menopausa, vampate e controindicazioni alla terapia ormonale sostitutiva. Quale soluzione? Interviene il dott. Marco Gambacciani

Bibliografia

1. Thurston RC, Aslanidou Vlachos HE, Derby CA, Jackson EA, Brooks MM, Matthews KA, Harlow S, Joffe H, El Khoudary SR.  Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. J Am Heart Assoc. 2021 Feb
2. Matthews KA, El Khoudary SR, Brooks MM, Derby CA, Harlow SD, Barinas-Mitchell EJ, Thurston RC. Lipid Changes Around the Final Menstrual Period Predict Carotid Subclinical Disease in Postmenopausal Women.  Stroke. 2017
3. Thurston RC.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health. Climacteric. 2018
4. Moura C, Bernatsky S, Abrahamowicz M, Papaioannou A, Bessette L, Adachi J, Goltzman D, Prior J, Kreiger N, Towheed T, Leslie WD, Kaiser S, Ioannidis G, Pickard L, Fraser LA, Rahme E. Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS).  Osteoporos Int. 2014 May
5. Kripke DF, Langer RD, Kline LE.  Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open. 2012 Feb 
6. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012 Sep
7. Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. Botanicals and Their Bioactive Phytochemicals for Women’s Health. Pharmacol Rev. 2016 Oct
8. Beer AM, Osmers R, Schnitker J, Bai W, Mueck AO, Meden H.  Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms – comments on major statements of the Cochrane Collaboration report 2012 “black cohosh (Cimicifuga spp.) for menopausal symptoms (review)”. Gynecol Endocrinol. 2013 Dec
9. Raus K, Brucker C, Gorkow C, Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause. 2006 Jul-Aug
10. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005 Jan
11. Hirschberg AL, Edlund M, Svane G, Azavedo E, Skoog L, von Schoultz B.  An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause. 2007 Jan-Feb
12. Henneicke-von Zepelin HH, Meden H, Kostev K, Schröder-Bernhardi D, Stammwitz U, Becher H. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer.Int J Clin Pharmacol Ther. 2007 Mar
13. Jiang K, Jin Y, Huang L, Feng S, Hou X, Du B, Zheng J, Li LBlack cohosh improves objective sleep in postmenopausal women with sleep disturbance. Climacteric. 2015
14. Leach MJ, Moore V.Cochrane Black cohosh (Cimicifuga spp.) for menopausal symptoms. Database Syst Rev. 2012 Sep
15. Naser B, Schnitker J, Minkin MJ, de Arriba SG, Nolte KU, Osmers R.Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause. 2011 Apr
16. Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom BL.A retrospective case-control study of the use of hormone-related supplements and association with breast cancer.Int J Cancer. 2007 Apr
17. Huang YX, Song L, Zhang X, Lun WW, Pan C, Huang YS.Zhonghua Yi Xue Za Zhi.[Clinical study of combined treatment of remifemin and paroxetine for perimenopausal depression].2013 Feb
18. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH. Black cohosh with or without St. John’s wort for symptom-specific climacteric treatment–results of a large-scale, controlled, observational study. 2007 Aug 20